(a) Multivariable models for GDF8 and GDF11, respectively, with knee strength, adjusted by age, sex, and physical activity |
GDF8 mature |
−.08 |
0.06 |
.15 |
GDF11 mature |
.04 |
0.04 |
.38 |
(b) Multivariable model for GDF8 and circulating antagonists with knee strength, adjusted by age, sex, and physical activity |
GDF8 mature |
−.05 |
0.07 |
.43 |
GDF8 prodomain |
.002 |
0.04 |
.96 |
FST315 |
−.14 |
0.06 |
.02 |
FST303 |
−.003 |
0.004 |
.45 |
WFIKKN1 |
−.02 |
0.06 |
.69 |
WFIKKN2 |
.03 |
0.04 |
.37 |
(c) Multivariable model for GDF11 and circulating antagonists with knee strength, adjusted by age, sex, and physical activity |
GDF11 mature |
.10 |
0.08 |
.18 |
GDF11 prodomain |
.07 |
0.06 |
.27 |
FST315 |
−.18 |
0.08 |
.02 |
FST303 |
.005 |
0.01 |
.45 |
WFIKKN1 |
−.18 |
0.07 |
.02 |
WFIKKN2 |
.06 |
0.05 |
.30 |
(d) Multivariable model for GDF8 and GDF11 and their circulating antagonists with knee strength, adjusted by age, sex, and physical activity |
GDF8 mature |
−.10 |
0.08 |
.22 |
GDF8 prodomain |
.001 |
0.05 |
.98 |
GDF11 mature |
.10 |
0.07 |
.19 |
GDF11 prodomain |
.09 |
0.06 |
.18 |
FST315 |
−.18 |
0.07 |
.02 |
FST303 |
.005 |
0.01 |
.50 |
WFIKKN1 |
−.16 |
0.07 |
.03 |
WFIKKN2 |
.08 |
0.06 |
.18 |